Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
Top Sells
| 1 |
FIGY
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
|
+$1.59B |
| 2 |
FEEU
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
|
+$464M |
| 3 |
Citigroup
C
|
+$340M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
CAA
CalAtlantic Group, Inc.
CAA
|
+$123M |
Sector Composition
| 1 | Financials | 16.58% |
| 2 | Technology | 14.9% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Consumer Staples | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
HSBC
HSBC
$336B
| $702M | 0.93% |
15,776,588
+195,702
| +1% | +$9.31M |
|
27
PepsiCo
PEP
$189B
| $684M | 0.91% |
6,268,697
+187,669
| +3% | +$21.3M |
|
28
HDFC Bank
HDB
$136B
| $679M | 0.9% |
27,492,828
-4,218,160
| -13% | -$106M |
|
29
AB InBev
BUD
$153B
| $675M | 0.9% |
6,144,032
+147,016
| +2% | +$16.3M |
|
|
NVO
30
Novo Nordisk
NVO
$218B
| $647M | 0.86% |
26,259,314
+848,360
| +3% | +$22.3M |
|
31
Berkshire Hathaway Class B
BRK.B
$1.07T
| $637M | 0.84% |
3,191,835
+155,804
| +5% | +$32M |
|
|
BAY
32
DELISTED
BAYER AG SPONS ADR
BAY
| $612M | 0.81% |
21,668,714
+830,372
| +4% | +$23.4M |
|
33
Sanofi
SNY
$105B
| $604M | 0.8% |
15,073,452
+572,694
| +4% | +$23.8M |
|
34
Oracle
ORCL
$379B
| $602M | 0.8% |
13,151,741
+583,326
| +5% | +$29M |
|
35
Banco Santander
SAN
$196B
| $584M | 0.77% |
93,069,055
+3,917,330
| +4% | +$25.9M |
|
36
Novartis
NVS
$293B
| $566M | 0.75% |
7,819,225
+211,871
| +3% | +$16.1M |
|
37
JPMorgan Chase
JPM
$896B
| $550M | 0.73% |
5,003,395
+130,408
| +3% | +$14.8M |
|
|
FIEE
38
DELISTED
FI Enhanced Europe 50 ETN
FIEE
| $540M | 0.72% |
3,264,950
-4,113
| -0.1% | -$728K |
|
39
iShares MBS ETF
MBB
$39.1B
| $529M | 0.7% |
5,057,138
+461,572
| +10% | +$48.4M |
|
40
GSK
GSK
$105B
| $525M | 0.7% |
10,742,675
+518,898
| +5% | +$24.2M |
|
41
RTX Corp
RTX
$264B
| $495M | 0.66% |
6,254,949
+214,318
| +4% | +$17.7M |
|
42
Chevron
CVX
$363B
| $482M | 0.64% |
4,228,966
+191,111
| +5% | +$22.8M |
|
43
Sumitomo Mitsui Financial
SMFG
$165B
| $471M | 0.62% |
55,376,036
+2,429,565
| +5% | +$21.7M |
|
44
Costco
COST
$411B
| $469M | 0.62% |
2,488,816
+162,335
| +7% | +$30.6M |
|
45
Trip.com Group
TCOM
$26.7B
| $460M | 0.61% |
9,869,712
-198,741
| -2% | -$9.32M |
|
46
AstraZeneca
AZN
$263B
| $439M | 0.58% |
6,272,080
+313,414
| +5% | +$21.7M |
|
47
JD.com
JD
$39B
| $435M | 0.58% |
10,739,720
-244,901
| -2% | -$11.1M |
|
|
FFEU
48
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
| $431M | 0.57% |
+4,351,098
| New | +$423M |
|
49
Lloyds Banking Group
LYG
$85.6B
| $430M | 0.57% |
115,600,470
-7,405,788
| -6% | -$28.7M |
|
50
ASML
ASML
$665B
| $427M | 0.57% |
2,150,698
+75,417
| +4% | +$14.8M |
|
Similar funds
